We are live on ! Find out more
RHBC

R.H. Bluestein & Co Portfolio holdings

AUM $1.61B
1-Year Est. Return 7.59%
This Fund
S&P 500
This Quarter Est. Return
+2.53%
1 Year Est. Return
-7.59%
3 Year Est. Return
+69.02%
5 Year Est. Return
+139.59%
10 Year Est. Return
–
AUM
$1.52B
AUM Growth
+$214M
Cap. Flow
+$201M
Cap. Flow %
13.22%
Top 10 Hldgs %
33.88%
Holding
311
New
21
Increased
84
Reduced
44
Closed
15

Top Buys

Rank Stock Value
1
CB icon
Chubb
CB
+$24.9M
2
SYK icon
Stryker
SYK
+$24.6M
3
APA icon
APA Corp
APA
+$23.1M
4
NUE icon
Nucor
NUE
+$21.9M
5
CMCSA icon
Comcast
CMCSA
+$18.9M

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$32.8M
2
HBI
Hanesbrands
HBI
+$15.1M
3
CHD icon
Church & Dwight Co
CHD
+$9.02M
4
NEE icon
NextEra Energy
NEE
+$9M
5
KO icon
Coca-Cola
KO
+$5.35M

Sector Composition

Rank Sector Weight
1 Industrials 15.33%
2 Materials 13.93%
3 Communication Services 13.6%
4 Healthcare 10.39%
5 Energy 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPLK
251
DELISTED
Splunk Inc
SPLK
$235K 0.02%
4,000
– –
XYZ
252
Block Inc
XYZ
$48.4B
$233K 0.02%
20,000
– –
SNV
253
DELISTED
Synovus
SNV
$232K 0.02%
7,142
– –
CAJ
254
DELISTED
Canon, Inc.
CAJ
$232K 0.02%
8,000
– –
AEGN
255
DELISTED
Aegion Corp
AEGN
$229K 0.02%
12,000
– –
CCC
256
DELISTED
Calgon Carbon Corp
CCC
$228K 0.02%
15,000
– –
SAN icon
257
Banco Santander
SAN
$201B
$225K 0.01%
53,283
– –
FDX icon
258
FedEx
FDX
$72.7B
$223K 0.01%
+1,278
New +$209K
INVX
259
Innovex International
INVX
$1.96B
$223K 0.01%
4,000
– –
TD icon
260
Toronto Dominion Bank
TD
$198B
$222K 0.01%
5,000
-100
-2% -$4.38K
BKNG icon
261
Booking.com
BKNG
$149B
$221K 0.01%
3,750
-2,125
-36% -$118K
GNRC icon
262
Generac Holdings
GNRC
$11.6B
$218K 0.01%
+6,000
New +$217K
LNG icon
263
Cheniere Energy
LNG
$55.2B
$218K 0.01%
+5,000
New +$211K
FLS icon
264
Flowserve
FLS
$9.71B
$217K 0.01%
4,500
– –
DE icon
265
Deere & Co
DE
$160B
$213K 0.01%
2,500
– –
RIG icon
266
Transocean
RIG
$5.89B
$213K 0.01%
20,000
– –
BWA icon
267
BorgWarner
BWA
$13.1B
$211K 0.01%
+6,816
New +$201K
CVS icon
268
CVS Health
CVS
$133B
$210K 0.01%
2,360
– –
MU icon
269
Micron Technology
MU
$930B
$210K 0.01%
+11,800
New +$180K
MHK icon
270
Mohawk Industries
MHK
$7.5B
$206K 0.01%
+1,027
New +$211K
BRFS
271
DELISTED
BRF SA
BRFS
$205K 0.01%
12,000
– –
FLR icon
272
Fluor
FLR
$7.01B
$205K 0.01%
+4,000
New +$206K
UNFI icon
273
United Natural Foods
UNFI
$3.08B
$200K 0.01%
5,000
– –
SRCL
274
DELISTED
Stericycle Inc
SRCL
$200K 0.01%
2,500
– –
WIT icon
275
Wipro
WIT
$19.6B
$194K 0.01%
106,667
– –
9 10
11
12 13

Similar funds

BDF
Balasa Dinverno & Foltz $1.58B AUM 17.55% 1-Year Est. Return
ACM
AlphaCrest Capital Management New York $1.64B AUM 23.4% 1-Year Est. Return
SCA
Salient Capital Advisors Houston, Texas $1.74B AUM 12.95% 1-Year Est. Return
WFA
Wipfli Financial Advisors Milwaukee, Wisconsin $1.42B AUM 20.63% 1-Year Est. Return
IC
Inverness Counsel New York $1.8B AUM 9.9% 1-Year Est. Return
CA
Capitolis Advisors New York $1.41B AUM 17.33% 1-Year Est. Return
RIG
Roosevelt Investment Group New York $1.39B AUM 5.42% 1-Year Est. Return
CCP
Corient Capital Partners Newport Beach, California $1.34B AUM 12.46% 1-Year Est. Return

R.H. Bluestein & Co's Q3 2016 Portfolio in Review

As of Q3 2016, R.H. Bluestein & Co held 311 positions worth $1.52B, up 16% from $1.31B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

R.H. Bluestein & Co deployed $201M of net new capital in Q3 2016, opening 21 new positions and adding to 84 existing holdings. Its largest new stake was APA Corp: 423,532 shares worth $27.1M.

By sector, the portfolio is most concentrated in Industrials at 15% of assets, down from 16% a quarter earlier, followed by Materials and Communication Services.

On the sell side, the largest reduction was Boston Scientific, an estimated $32.8M trimmed.

  • R.H. Bluestein & Co's largest Q3 2016 buy was APA Corp: 423,532 shares worth $27.1M.
  • R.H. Bluestein & Co added most to Chubb in Q3 2016, an estimated $24.9M increase.
  • R.H. Bluestein & Co's biggest Q3 2016 reduction was Boston Scientific, cutting an estimated $32.8M.
  • R.H. Bluestein & Co fully exited Hanesbrands in Q3 2016, selling an estimated $15.1M.
  • R.H. Bluestein & Co's ten largest holdings make up 34% of its $1.52B portfolio in Q3 2016.
  • R.H. Bluestein & Co opened 21 new positions and closed 15 in Q3 2016.
  • R.H. Bluestein & Co's portfolio value rose 16% quarter-over-quarter to $1.52B.

Based on R.H. Bluestein & Co's 13F filing for Q3 2016, filed 14 Nov 2016.